Literature DB >> 6573312

Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study.

G Ruckdeschel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6573312     DOI： 10.1093/jac/11.suppl_a.117

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Toxicity and clearance of intravitreal cefotetan.

Authors:  W Philipp; K Schmid; H J Steiner; B Pümpel; F Allerberger; H P Aichberger; W Mayer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

3.  In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.

Authors:  M J Ohm-Smith; R L Sweet
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

Review 4.  Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Ward; D M Richards
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

5.  In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria.

Authors:  H M Wexler; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

6.  Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.

Authors:  L Dubreuil; J Devos; C Neut; C Romond
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.